Last edition
News about
Granules Consumer Health completes US FDA audit with zero 483s
The packaging facility in Manassas is spread over 79,000 sq ft
Cellipont Bioservices announces strategic debt facility investment from OrbiMed
The 76,000 sq foot facility will feature significant capabilities including process and analytical development and manufacturing services for CAR-T, IPSC, MSC and other types of cell therapies
Samsung Biologics eyes strategic expansion in Korea
The company plans to begin construction in the first half of 2023 and commence operations in 2025
<br />
Bliss GVS Pharma gets three minor observations from US FDA for Palghar unit
The company will prepare a detailed response to the observations, which will be submitted to the US FDA within the stipulated timelines
US FDA conducts Pre-Approval Inspection of oral oncology manufacturing facility in Gujarat
The company has been issued a Form 483 with 1 observation, which is procedural
Eiko LifeSciences in MoU with Vivacious Pharmatex
Both companies will use their manufacturing facilities/ expanded capacities to manufacture the products identified and developed by ELL
France-based Bormioli Pharma sales increase more than 40 per cent YoY in US
The growth in North America was matched by strong sales gains in the company’s markets worldwide
Jubilant announces loan facility by Govt of Canada for CMO Montreal facility expansion
The loan is in addition to the earlier announced CAD 25 million loan committed by the Province of Quebec
SCHOTT launches production of amber pharma glass in India
The company starts production of FIOLAX amber pharmaceutical glass tubing
<br />
Sai Life Sciences unveils GMP Kilo Lab in Alderley Park, Manchester, UK
The new GMP Kilo Lab will enable Sai Life Sciences to offer drug substances and intermediates supplies ranging from gram to kilogram quantities
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy